Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Since its development and release in 2019, the Society for Cardiovascular Angiography and
Interventions (SCAI) shock stage classification for adult patients has been widely cited and …

Background Extracorporeal life support (ECLS) is increasingly used in the treatment of
infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality …

Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

Sepsis is the life-threatening organ dysfunction caused by a dysregulated host response to
infection and is the leading cause of death in intensive care units. Cardiac dysfunction …

We describe the first case of acute cardiac injury directly linked to myocardial localization of
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in a 69‐year‐old patient …

Over the past few decades, advances in pharmacological, catheter-based, and surgical
reperfusion have improved outcomes for patients with acute myocardial infarctions …

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) with substantial cardiovascular …

Background The outcome of cardiogenic shock complicating myocardial infarction has not
appreciably changed in the last 30 years despite the development of various percutaneous …

Fulminant myocarditis (FM) is an uncommon syndrome characterized by sudden and severe
diffuse cardiac inflammation often leading to death resulting from cardiogenic shock …